January 23, 2017
New York, NY / January 23, 2017 – WallStreet Research™ (WSR) has released a Corporate Profile Analyst Report for ChineseInvestors.com, Inc. (OTCQB:CIIX or the “Company WSR Corporate Profile includes financial, operations, marketing, investment, and other critical information about the Company. The Company’s core business is a leading dynamic financial information website www.Chinesefn.com. The Company provides a wide range of financial and market information to the global Chinese population, including real time news and also offers a wide variety of consultation and subscription services. The Company is now preparing to utilize its expertise in technology, web and media content and also is now poised to launch in an expanded business activity, online sales and retail of CBD oils to the Chinese markets globally thru its website www.ChineseCBDoil.com.
WallStreet Research™ (WSR), is a top-ranked independent research firm with a history spanning over three decades. WallStreet Research™ is ranked Number One on the Google, Yahoo, and Bing search engines in both and small and microcap research. WallStreet Research™ has released its analyst Corporate Profile Report on CIIX, and the report is now available at the www.WallStreetResearch.org website.
The recent WSR Corporate Profile highlights the Company’s accomplishments and growth plans under the guidance of the it’s management team, led by CEO Warren Wang.
WSR reports that the market for medical marijuana and derivative products, specifically the CBD oils market, is rapidly growing and the Company is well positioned to penetrate the adult Chinese-speaking population of over one billion globally. The Company is designing a new website and mobile app which will allow sales of CBD products to the Chinese speaking population both in the US and in China. The Company is working on wholesale agreements with well known CBD oil brands that will allow CBD oils to be marketed and sold online globally via the new www.ChineseCBDoil.com website and at retail through stores initially in Shanghai, China.
Mr. Alan Stone, Managing Director of WallStreet Research™, notes; “The Company’s recent announcements regarding expansion into the medical marijuana and CBD oil industry has driven great interest in CIIX shares. As a result, the shares have significantly increased in both market value and trading volume, potentially positioning the company for a listing either on the NASDAQ or the NYSE Markets sometime later in 2017.”
About WallStreet Research™
WallStreet Research™ (“WSR”) is a prominent research boutique led by Mr. Alan Stone, Managing Director of Alan Stone & Company, LLC (ASC). The firm specializes in the microcap and small cap investment arena, looking for emerging growth companies with strong management, unique or proprietary technology, significant market potential, financial strength, and outstanding long-term earnings growth possibilities. Mr. Stone was formerly a securities analyst and assistant portfolio manager at Merrill Lynch Asset Management, an investment analyst at Prudential Financial’s Capital Markets Group, and an investment banker with Ladenburg Thalmann & Company. The firm has offices in Los Angeles, CA, Palm Beach, FL, and New York City, NY, and is well known for discovering undervalued companies and bringing them to the attention of the investment community. ASC/WSR also arranges road shows for its publicly traded clients, before the investment community in New York City, California and Florida. Information on WallStreet Research™ can be found at www.WallStreetResearch.org.
About Chinese Investors:
ChineseInvestors.com, Inc. (OTCQB: CIIX), founded in 1999, endeavors to be a leading financial information website that provides real-time market commentary, analysis, and educational related services to Chinese-speaking investors via the company’s dynamic financial website, www.chinesefn.com. The Company went public on OTCQB in January 2012 under the symbol CIIX.
Contact Investor Relations:
Phone: +1 (214) 636-2548